Agilon Health Inc (AGL) concluded trading on Thursday at a closing price of $2.21, with 3.29 million shares of worth about $7.27 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -67.50% during that period and on December 05, 2024 the price saw a loss of about -0.90%. Currently the company’s common shares owned by public are about 411.96M shares, out of which, 303.27M shares are available for trading.
Stock saw a price change of 4.74% in past 5 days and over the past one month there was a price change of -19.05%. Year-to-date (YTD), AGL shares are showing a performance of -82.39% which decreased to -80.00% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.50 but also hit the highest price of $13.76 during that period. The average intraday trading volume for Agilon Health Inc shares is 4.68 million. The stock is currently trading 11.31% above its 20-day simple moving average (SMA20), while that difference is down -16.19% for SMA50 and it goes to -53.91% lower than SMA200.
Agilon Health Inc (NYSE: AGL) currently have 411.96M outstanding shares and institutions hold larger chunk of about 80.57% of that.
The stock has a current market capitalization of $910.56M and its 3Y-monthly beta is at 0.51. It has posted earnings per share of -$0.82 in the same period. It has Quick Ratio of 1.29 while making debt-to-equity ratio of 0.08. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AGL, volatility over the week remained 8.20% while standing at 10.44% over the month.
Stock’s fiscal year EPS is expected to drop by -19.13% while it is estimated to increase by 36.20% in next year.
On October 30, 2024, Citigroup Downgrade their recommendations, while on October 02, 2024, BofA Securities Downgrade their ratings for the stock with a price target of $3. Stock get a Neutral rating from Robert W. Baird on May 30, 2024.
